Saturday 17 October 2026
Export STIM’s income statement to Excel — free account
Neuronetics, Inc.
STIM Healthcare Medical Devices
Neuronetics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $149.2 million, up 99.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.08%, EPS grew 66.7%, free cash flow grew 62.1% and total debt rose 10.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.89
0.06
−3.08%
Follow STIM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 2 | 3 | 3 | 5 | 2 | 2 | 5 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(3.48) | (3.94) | (3.42) | (2.05) | (1.25) | (2.10) | (2.08) | 0.54 | — | — |
P/S ratio |
0.61 | 0.68 | 1.10 | 2.72 | 2.05 | 4.25 | 1.32 | 3.28 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(10.38) | (9.80) | (7.73) | (6.98) | (2.21) | (8.62) | (5.01) | (0.02) | (14.75) | (23.95) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.59) | (1.57) | (2.16) | (2.28) | (2.36) | (2.17) | 1.51 | (2.30) | (2.67) | — |
P/Operating CF |
100.23 | (5.94) | 36.95 | (57.27) | (25.12) | (122.88) | (12.89) | (76.07) | (0.10) | (0.10) |
P/B ratio |
3.47 | 1.61 | 2.31 | 3.11 | 1.33 | 8.21 | 1.72 | 2.44 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 2.31 | 3.11 | 1.33 | 8.21 | 1.72 | 2.44 | 0.00 | 0.00 |
EV/Sales |
0.91 | 1.34 | 1.10 | 2.17 | 0.96 | 3.93 | 0.59 | 1.97 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(6.68) | (3.23) | (2.45) | (4.61) | (1.90) | (6.82) | (1.22) | (5.05) | (0.20) | (0.20) |
EV/FCF |
(6.43) | (3.09) | (2.28) | (4.16) | (1.76) | (6.65) | (1.19) | (4.81) | (0.19) | (0.19) |
Quick Ratio |
1.68 | 1.41 | 3.96 | 2.58 | 6.63 | 4.24 | 3.00 | 8.13 | 2.79 | 1.55 |
Current Ratio |
2.02 | 1.86 | 4.73 | 2.98 | 7.34 | 4.75 | 3.19 | 8.44 | 3.09 | 1.72 |
Net Debt/EBITDA |
(1.12) | (1.09) | 0.05 | 1.07 | 2.28 | 0.73 | 1.76 | 3.91 | (0.03) | (0.36) |
Debt/Assets |
46.49% | 39.14% | 51.18% | 30.76% | 25.50% | 44.77% | 31.10% | 25.97% | 75.91% | 81.21% |
Debt/Equity |
2.51 | 1.73 | 1.73 | 0.63 | 0.42 | 1.38 | 0.65 | 0.43 | (5.36) | (4.18) |
Asset Turnover |
1.06 | 0.58 | 0.61 | 0.51 | 0.50 | 0.55 | 0.58 | 0.68 | 1.27 | 1.07 |
Operating CF/Net income |
0.52 | 0.71 | 1.06 | 0.83 | 0.90 | 1.03 | 1.05 | 0.85 | 0.69 | 0.76 |
Capex/Depreciation |
(0.23) | (0.71) | (1.18) | (1.98) | (2.22) | (0.78) | (0.76) | (1.15) | (1.00) | (0.48) |
Interest Coverage |
(3.74) | (4.74) | (5.63) | (8.26) | (6.86) | (4.93) | (7.31) | (5.38) | (4.85) | (5.09) |
| (134.39%) | (132.47%) | (66.17%) | (52.25%) | (56.37%) | (74.86%) | (48.86%) | 39.63% | 8.69% | 6.08% | |
| (27.61%) | (34.05%) | (25.95%) | (28.79%) | (28.37%) | (30.70%) | (26.75%) | (30.90%) | (50.39%) | (35.25%) | |
ROIC |
(34.06%) | (32.11%) | (58.06%) | (103.82%) | (69.35%) | (141.37%) | (697.81%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(109.87%) | (132.05%) | (39.73%) | (55.00%) | (30.93%) | (52.73%) | (46.95%) | (23.56%) | (60.90%) | (100.21%) |
Average Days of Receivables |
41.34 | 118.36 | 91.26 | 77.37 | 51.34 | 53.11 | 38.27 | 38.87 | 38.52 | 38.14 |
Research and Development Expense of Revenue |
4.41% | 17.05% | 13.34% | 14.32% | 14.32% | 18.68% | 21.94% | 15.60% | 19.63% | 24.02% |
Selling, General and Administrative Expense of Revenue |
65.14% | 101.42% | 101.96% | 115.78% | 114.44% | 103.16% | 96.48% | 98.40% | 90.20% | 83.91% |
Intangible Assets out of Total Assets |
0.30 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4.59% | 7.48% | 10.26% | 13.41% | 14.23% | 8.94% | 5.48% | 3.30% | 1.23% | 0.47% |
Graham Net Nets |
(0.59) | (1.00) | 0.15 | 0.22 | 0.52 | 0.06 | 0.44 | 0.40 | 28.17 | 28.17 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(42.75%) | (85.09%) | (38.91%) | (20.91%) | (26.91%) | (13.14%) | (35.41%) | (287.15%) | (43.06%) | (43.06%) |
Free Cash Flow Yield |
(23.27%) | (63.54%) | (43.66%) | (19.16%) | (26.70%) | (13.92%) | (37.92%) | (12.48%) | (2,499.02%) | (2,499.02%) |
Revenue per Share |
2.26 | 2.36 | 2.49 | 2.42 | 2.17 | 2.61 | 3.41 | 5.90 | 217.38 | 234.44 |
Operating CF per Share |
(0.31) | (0.98) | (1.12) | (1.14) | (1.10) | (1.51) | (1.66) | (2.30) | (59.91) | (58.50) |
Capex per Share |
(0.01) | (0.05) | (0.08) | (0.12) | (0.09) | (0.04) | (0.04) | (0.11) | (3.19) | (2.22) |
Free Cash Flow per Share |
(0.32) | (1.02) | (1.20) | (1.26) | (1.19) | (1.55) | (1.70) | (2.41) | (63.11) | (60.72) |
Cash per Share |
0.52 | 0.62 | 2.11 | 2.67 | 3.78 | 2.70 | 4.17 | 11.69 | 156.70 | 116.71 |
Shareholders Equity per Share |
0.40 | 1.00 | 1.19 | 2.12 | 3.34 | 1.35 | 2.60 | 7.94 | (29.66) | (32.97) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.40 | 1.00 | 1.19 | 2.12 | 3.34 | 1.35 | 2.60 | 7.94 | (29.66) | (32.97) |
Free Cash Flow |
(21.17) | (32.46) | (34.41) | (34.01) | (30.34) | (29.12) | (31.29) | (21.60) | (11.74) | (8.86) |
Working Capital |
31.03 | 26.86 | 73.98 | 65.57 | 99.63 | 51.33 | 60.76 | 100.91 | 25.01 | 9.58 |
Capital Expenditures |
(0.80) | (1.47) | (2.37) | (3.27) | (2.35) | (0.73) | (0.81) | (1.01) | (0.59) | (0.32) |
Net Current Asset Value |
(53.76) | (50.98) | 12.15 | 38.95 | 59.28 | 11.85 | 36.14 | 68.49 | (7.45) | (6.69) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.02 | 0.03 | 0.05 | 0.04 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.78 | 0.33 | 1.00 | 0.83 | 0.87 | 1.29 | 0.96 | 0.64 | 0.44 | 0.41 |
Cash ROIC |
(16.75%) | (30.45%) | (22.33%) | (20.62%) | (13.95%) | (26.10%) | (20.11%) | (10.49%) | (22.07%) | (27.39%) |
Accounts Receivable Turnover |
7.24 | 3.56 | 4.51 | 6.04 | 7.40 | 7.17 | 10.28 | 10.68 | 10.31 | 8.73 |
Accounts Payable Turnover |
7.05 | 2.62 | 5.47 | 4.60 | 2.90 | 2.76 | 3.67 | 3.97 | 4.82 | 3.31 |
Inventory Turnover |
17.92 | 3.36 | 2.31 | 2.00 | 2.27 | 3.56 | 5.91 | 5.08 | 4.63 | 3.18 |
Average Days of Payables |
51.01 | 195.05 | 88.30 | 57.36 | 134.66 | 118.43 | 109.70 | 110.14 | 95.23 | 81.74 |
Days of Inventory on Hand |
20.55 | 74.80 | 150.38 | 209.79 | 205.57 | 117.52 | 65.82 | 71.32 | 93.52 | 93.48 |
Average Receivables |
20.59 | 21.06 | 15.83 | 10.80 | 7.47 | 6.87 | 6.09 | 4.94 | 3.92 | 3.92 |
Average Payables |
10.91 | 7.91 | 3.59 | 3.37 | 4.02 | 4.19 | 4.19 | 3.13 | 2.00 | 2.00 |
Average Inventory |
4.29 | 6.17 | 8.50 | 7.73 | 5.14 | 3.25 | 2.60 | 2.45 | 2.08 | 2.08 |
Average Assets |
141.23 | 128.37 | 116.36 | 129.05 | 109.94 | 89.41 | 108.60 | 77.98 | 31.87 | 31.87 |
Average Common Equity |
29.02 | 32.99 | 45.63 | 71.12 | 55.33 | 36.67 | 59.45 | (60.80) | (184.89) | (184.89) |
Columns are period end dates